Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season

BACKGROUND: Higher rates of influenza-related morbidity and mortality occur in individuals with underlying medical conditions. To improve vaccine effectiveness, cell-based technology for influenza vaccine manufacturing has been developed. Cell-derived inactivated quadrivalent influenza vaccines (cII...

Descripción completa

Detalles Bibliográficos
Autores principales: Boikos, Constantina, Imran, Mahrukh, Nguyen, Van Hung, Ducruet, Thierry, Sylvester, Gregg C, Mansi, James A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314952/
https://www.ncbi.nlm.nih.gov/pubmed/34327253
http://dx.doi.org/10.1093/ofid/ofab167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314952/
https://www.ncbi.nlm.nih.gov/pubmed/34327253
http://dx.doi.org/10.1093/ofid/ofab167

Ejemplares similares